SLC5A1 inhibition can protect against myocardial infarction-induced ventricular remodeling and heart failure in mice by replenishing ATP stores in ischemic cardiac tissues by enhancing glucose availability [38]. Here, SLC5A1 is linked to myocardial infarction.